176 related articles for article (PubMed ID: 35435865)
21. Evolution tumour models paving the way for understanding oral carcinogenesis.
Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
[TBL] [Abstract][Full Text] [Related]
22. The clinical utility of contemporary oral epithelial dysplasia grading systems.
Sathasivam HP; Sloan P; Thomson PJ; Robinson M
J Oral Pathol Med; 2022 Feb; 51(2):180-187. PubMed ID: 34797585
[TBL] [Abstract][Full Text] [Related]
23. Point-of-care Analysis for Non-invasive Diagnosis of Oral cancer (PANDORA): A technology-development proof of concept diagnostic accuracy study of dielectrophoresis in patients with oral squamous cell carcinoma and dysplasia.
Hughes MP; Labeed FH; Hoettges KF; Porter S; Mercadante V; Kalavrezos N; Liew C; McCaul JA; Kulkarni R; Cymerman J; Kerawala C; Barber J; Lewis MP; Fedele S
J Oral Pathol Med; 2023 Apr; 52(4):305-314. PubMed ID: 36811206
[TBL] [Abstract][Full Text] [Related]
24. Recent Developments in Oral Epithelial Dysplasia Grading: A Critical Appraisal.
Patil S; Rao RS; Raj AT
J Contemp Dent Pract; 2015 Oct; 16(10):i. PubMed ID: 26581468
[TBL] [Abstract][Full Text] [Related]
25. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.
Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S
J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679
[TBL] [Abstract][Full Text] [Related]
26. Assessment of apoptotic index in various grades of oral epithelial dysplasia: A cross-sectional study.
Pawar RB; Palaskar SJ; Kalavankar SS
Indian J Pathol Microbiol; 2020; 63(4):534-537. PubMed ID: 33154301
[TBL] [Abstract][Full Text] [Related]
27. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
Cao J; Jin JQ; Deng DJ; Liu HW
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
[TBL] [Abstract][Full Text] [Related]
28. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
29. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
30. Screening for oral potentially malignant epithelial lesions and squamous cell carcinoma: a discussion of benefit and risk.
Epstein JB
J Can Dent Assoc; 2014; 80():e47. PubMed ID: 25055237
[No Abstract] [Full Text] [Related]
31. Interobserver agreement in dysplasia grading: toward an enhanced gold standard for clinical pathology trials.
Speight PM; Abram TJ; Floriano PN; James R; Vick J; Thornhill MH; Murdoch C; Freeman C; Hegarty AM; D'Apice K; Kerr AR; Phelan J; Corby P; Khouly I; Vigneswaran N; Bouquot J; Demian NM; Weinstock YE; Redding SW; Rowan S; Yeh CK; McGuff HS; Miller FR; McDevitt JT
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):474-82.e2. PubMed ID: 26216170
[TBL] [Abstract][Full Text] [Related]
32. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
33. Oral epithelial dysplasia in non-users of tobacco and alcohol: an analysis of clinicopathologic characteristics and treatment outcome.
Jaber MA
J Oral Sci; 2010 Mar; 52(1):13-21. PubMed ID: 20339228
[TBL] [Abstract][Full Text] [Related]
34. Oral Potentially Malignant Disorders (OPMD): What is the clinical utility of dysplasia grade?
Pritzker KPH; Darling MR; Hwang JT; Mock D
Expert Rev Mol Diagn; 2021 Mar; 21(3):289-298. PubMed ID: 33682567
[TBL] [Abstract][Full Text] [Related]
35. Readdressing dysplasia at surgical margins as predictive biomarker of malignant transformation.
Sarode GS; Sarode SC; Sengupta N; Sharma NK; Patil S
Oral Oncol; 2021 Jun; 117():105181. PubMed ID: 33500183
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical evaluation of E-cadherin in oral epithelial dysplasia and squamous cell carcinoma.
Sharma J; Bhargava M; Aggarwal S; Aggarwal A; Varshney A; Chopra D
Indian J Pathol Microbiol; 2022; 65(4):755-760. PubMed ID: 36308176
[TBL] [Abstract][Full Text] [Related]
37. Reliability of toluidine blue application in the detection of oral epithelial dysplasia and in situ and invasive squamous cell carcinomas.
Onofre MA; Sposto MR; Navarro CM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):535-40. PubMed ID: 11346731
[TBL] [Abstract][Full Text] [Related]
38. Histologic lichenoid features in oral dysplasia and squamous cell carcinoma.
Fitzpatrick SG; Honda KS; Sattar A; Hirsch SA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Apr; 117(4):511-20. PubMed ID: 24560560
[TBL] [Abstract][Full Text] [Related]
39. Histopathological findings of oral epithelial dysplasias and their relation to malignant transformation.
Ellonen R; Suominen A; Kelppe J; Willberg J; Rautava J; Laine H
Cancer Treat Res Commun; 2023; 34():100664. PubMed ID: 36481601
[TBL] [Abstract][Full Text] [Related]
40. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
